Florida Institute of Technology, in conjunction with the University of Miami Miller School of Medicine, will offer participating medical providers a CME-accredited course for CVD and ANS testing. The course covers the subject matter in significant detail including clinical, scientific and billing-related curriculum. This is a distance course that allows qualified providers to participate on their own schedules and provides proctored exams for each of the six modules followed by a final exam.

There is an option for 6 CME credits available toward medical licensure in most states.

This is the only course of its kind at this time and includes comprehensive material taught by some of the most noted and published instructors on the subject matter. Join the elite group of providers who offer noninvasive testing for heart rate variability, pulse wave velocity and sudomotor function by participating in this instructional series.

Stay ahead of the curve and acquire additional breadth, depth and scope of knowledge that no other CE series on the subject matter offers.

Provides an overview of the autonomic nervous system (ANS). Explains why ANS function tests include measurement of heart rate variability (HRV) from electrocardiography (ECG) recordings, pulse wave velocity (PWV) measurements from photoplethysmography (PPG) recordings, sudomotor function testing using quantitative sudomotor axon reflex test (QSART) and sympathetic skin response (SSR) test, are very important. Provides a short overview of these three tests, with added detail information.

Request Information


Dr. Mehmet Kaya,
Assistant Professor, Biomedical and Chemical Engineering and Sciences

Dr. Kaya's research interests focus on cardiovascular research, ultrasound imaging and therapeutics, biosensors and medical devices. He has worked on projects including a Human Patient Simulator, a seizure and epilepsy detector, a medical device to stop excessive menstrual bleeding, ultrasound image-guided release of oxygen to hypoxic tumor to enhance cancer radiotherapy, stem cells and ultrasound to treat vascular injury due to stent placement and noninvasive detection of cardiac arrhythmia to identify which patients are at the highest risk of sudden death. Specific areas of interest include developing innovative techniques and devices for the detection and therapy of cardiovascular diseases such as myocardial ischemia, cardiac arrhythmia, hypertension, hemorrhagic shock and procedures including angioplasty/stent placement and hemodynamic monitoring. In addition, Dr. Kaya is also interested in the development of contrast agents and ultrasound technology for the diagnosis and therapy of diseases, including cancer.